The Regulation of Human Genome Editing-Reference-Cited by-同舟云学术

The Regulation of Human Genome Editing

Published:2023-01 Issue: Volume: Page:40-59
ISSN:
Container-title:An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology
language:
Short-container-title:

Author:

Stasi Alessandro¹,Chiang David Tan Weng¹

Affiliation:

1. Mahidol University International College,College in Salaya,Thailand,

Abstract

With the progress of DNA sequencing technology and its falling costs, the number of gene patents is dramatically growing. This chapter aims to shed light on the regulation of human genome editing and its impact on health research. By analyzing legal provisions and cases, this paper assesses whether genetically modified forms of life meet the statutory requirements of utility, novelty, and non-obviousness under patent law. The nature of the patentable subject matter of living organisms and genes in the U.S. is also examined in detail.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference12 articles.

1. USPTO US Patent Statistics Chart Calendar Years 1963 2020 https://www.uspto.gov/web/offices/ac/ ido/oeip/taf/us_stat.htm

2. Goodman H.M.; Shine J.; Seeburg P.H.; Recombinant DNA Transfer Vectors (U.S. Patent No. 4,363,877). U.S. Patent and Trademark Office. 1978

3. Rimmer M.; Genentech and the stolen gene: patent law and pioneer inventions. Bio-Science Law Review 2002,5(6),198-211

4. Gillis J.; 1999 https://www.washingtonpost.com/archive/politics/1999/05/17/20-years-later-stolen-gene-haunts-a-biotech-pioneer/de4c95df-32e0-4c49-bec4-069ceeea58ad/

5. Roberts L.; Davenport R.J.; Pennisi E.; Marshall E.; A History of the Human Genome Project. Science 2001,291(5507),1195-1200